Literature DB >> 16014684

Women with early rheumatoid arthritis are referred later than men.

Ø Palm1, E Purinszky.   

Abstract

OBJECTIVE: To evaluate lag times between disease onset and rheumatological encounter in patients with early rheumatoid arthritis (RA).
METHODS: All referred patients with early RA over a 1 year period were prospectively registered. The lag time between disease onset and the first encounter with a physician was recorded as the "patient's delay". The time between this encounter and the referral to our department was recorded as the "physician's delay". The lag time between referral and rheumatological encounter was recorded as the "hospital's delay".
RESULTS: The median total lag time between onset of RA and rheumatological encounter was 16 weeks, with no difference between men and women. Women were referred significantly later than men ("physician's delay" median 10 weeks v 3 weeks). The "patient's delay" and the "hospital's delay" were a median of 4 weeks each.
CONCLUSION: Women with early RA were referred later than men and the total lag time between disease onset and rheumatological encounter was quite long for both sexes.

Entities:  

Mesh:

Year:  2005        PMID: 16014684      PMCID: PMC1755586          DOI: 10.1136/ard.2004.031716

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  10 in total

1.  Personal attributes as determinants of timely care in rheumatoid arthritis.

Authors:  G H Esselens; A De Brabander; L Ovaere; G De Brabanter; P Moons; R Westhovens
Journal:  Ann Rheum Dis       Date:  2006-07       Impact factor: 19.103

2.  Women's accounts of help-seeking in early rheumatoid arthritis from symptom onset to diagnosis.

Authors:  Anne Townsend; Catherine L Backman; Paul Adam; Linda C Li
Journal:  Chronic Illn       Date:  2014-02-24

3.  The impact of gender on time to rheumatoid arthritis classification: a retrospective analysis of a population-based cohort.

Authors:  Caitrin M Coffey; John M Davis; Cynthia S Crowson
Journal:  Rheumatol Int       Date:  2019-07-23       Impact factor: 2.631

4.  Lower odds of remission among women with rheumatoid arthritis: A cohort study in the Swiss Clinical Quality Management cohort.

Authors:  Enriqueta Vallejo-Yagüe; Julia N Pfund; Theresa Burkard; Carole Clair; Raphael Micheroli; Burkhard Möller; Axel Finckh; Andrea M Burden
Journal:  PLoS One       Date:  2022-10-20       Impact factor: 3.752

Review 5.  Sex and Management of Rheumatoid Arthritis.

Authors:  Ennio Giulio Favalli; Martina Biggioggero; Chiara Crotti; Andrea Becciolini; Maria Gabriella Raimondo; Pier Luigi Meroni
Journal:  Clin Rev Allergy Immunol       Date:  2019-06       Impact factor: 8.667

6.  Lag time between onset of symptoms and diagnosis in Venezuelan patients with rheumatoid arthritis.

Authors:  Elaudi Rodríguez-Polanco; Soham Al Snih; Yong-Fang Kuo; Alberto Millán; Martín A Rodríguez
Journal:  Rheumatol Int       Date:  2010-01-12       Impact factor: 2.631

7.  Use of Rheumatologic Testing in Patients Who Eventually Receive a Diagnosis of Rheumatoid Arthritis.

Authors:  Dilpreet K Singh; Jasdeep Badwal; Ritika Vankina; Santhi Gokaraju; Jennifer Friderici; Scott Halista; Tara Lagu
Journal:  South Med J       Date:  2019-10       Impact factor: 0.954

Review 8.  Help-seeking trajectory in patients with rheumatoid arthritis.

Authors:  Ingris Pelaez; Claudia Infante; Rosana Quintana
Journal:  Clin Rheumatol       Date:  2015-07-23       Impact factor: 2.980

9.  Prevalence and clinical characteristics of rheumatoid arthritis in Poland: a nationwide study.

Authors:  Bogdan Batko; Marcin Stajszczyk; Jerzy Świerkot; Karol Urbański; Filip Raciborski; Mariusz Jędrzejewski; Piotr Wiland
Journal:  Arch Med Sci       Date:  2017-12-13       Impact factor: 3.318

10.  Diagnostic delay in patients with rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis: results from the Danish nationwide DANBIO registry.

Authors:  Jan Sørensen; Merete Lund Hetland
Journal:  Ann Rheum Dis       Date:  2014-02-17       Impact factor: 19.103

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.